Severe COVID-19 with hypoxia
COVID-19 with hypoxaemia (SpO2 below 94 % on room air, need for supplemental oxygen) or critical illness (mechanical ventilation, ECMO). In this group, anti-inflammatory corticosteroid therapy reduces mortality – demonstrated in RECOVERY (NEJM 2021). Managed in hospital.
ICD-10 U07.12 drugs
Also known as: Hospitalized COVID-19, Oxygen-dependent COVID-19
Drugs used for this condition
Marketing claims without evidence base
The drug is promoted for these uses outside international guidelines. Each entry below is analyzed against AEMPS, FDA, EMA, Cochrane and major RCTs.
How to read tiers A–F
Evidence tiers belong to the drug-indication pair, not to the drug as a whole: the same substance can be A for one condition and F for another.
- AStrong evidence – first or second line in international guidelines
- BRecommended in selected cases
- CStudy data contradict each other
- DBenefit not proven, no documented harm
- FDocumented harm, or risk without benefit